A role for iron in Wnt signalling

Oncogene

Volumn 27, Issue 7, 2008, Pages 966-975

  Brookes, M J ^a,b   Boult, J ^a   Roberts, K ^a   Cooper, B T ^b   Hotchin, N A ^a   Matthews, G ^a   Iqbal, T ^a   Tselepis, C ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

Colon; E cadherin; Iron; Wnt

Indexed keywords

BETA CATENIN; IRON; MESSENGER RNA; MYC PROTEIN; NKD1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN;

ARTICLE; CARCINOGENESIS; CELL LINE; CELL PROLIFERATION; CELL STRAIN HEK293; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION;

ADENOMATOUS POLYPOSIS COLI PROTEIN; BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CARRIER PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; COLORECTAL NEOPLASMS; FERROUS COMPOUNDS; FIBROBLASTS; HUMANS; LUCIFERASES; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 38949196365     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210711     Document Type: Article

References (38)

1. Bienz M, Clevers H. (2000). Linking colorectal cancer to Wnt signalling. Cell 103: 311-320.
2. Brookes MJ, Hughes S, Turner FE, Reynolds G, Sharma N, Ismail T et al. (2006). Modulation of iron transport proteins in human colorectal carcinogenesis. Gut 55: 1449-1460.
3. Chao A, Thun MJ, Connell CJ, McCullough ML, Jacobs EJ, Flanders WD et al. (2005). Meat consumption and risk of colorectal cancer. JAMA 293: 172-182.
4. Clevers H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
5. Fodde R, Smits R, Clevers H. (2001). APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1: 55-67.
6. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H et al. (1991). Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600.
7. Habel ME, Jung D. (2006). c-Myc over-expression in Ramos Burkitt's lymphoma cell line predisposes to iron homeostasis disruption in vitro. Biochem Biophys Res Commun 341: 1309-1316.
8. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
9. Ilsley JN, Belinsky GS, Guda K, Zhang Q, Huang X, Blumberg JB et al. (2004). Dietary iron promotes azoxymethane-induced colon tumors in mice. Nutr Cancer 49: 162-169.
10. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB et al. (1991). Identification of FAP locus genes from chromosome 5q21. Science 253: 661-665.
11. Kolligs FT, Hu G, Dang CV, Fearon ER. (1999). Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol Cell Biol 19: 5696-5706.
12. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW et al. (1997). Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787.
13. Latunde-Dada GO, Simpson RJ, McKie AT. (2006). Recent advances in mammalian haem transport. Trends Biochem Sci 31: 182-188.
14. Lee DH, Anderson KE, Harnack LJ, Folsom AR, Jacobs Jr DR. (2004). Heme iron, zinc, alcohol consumption, and colon cancer. J Natl Cancer Inst 96: 403-407.
15. Maines MD, Gibbs PE. (2005). 30 some years of heme oxygenase. Biochem Biophys Res Commun 338: 568-577.
16. Mainous AG, Gill JM, Everett CJ. (2005). Transferrin saturation, dietary iron intake, and risk of cancer. Ann Fam Med 3: 131-137.
17. Miranda E, Destro A, Malesci A, Balladore E, Bianchi P, Baryshnikova E et al. (2006). Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer 95: 1101-1107.
18. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S et al. (1992). Somatic mutations of the APC gene in colorectal tumors. Hum Mol Genet 1: 229-233.
19. Munro SB, Turner IM, Farookhi R, Blaschuk OW, Jothy S. (1995). E-cadherin and OB-cadherin mRNA levels in normal human colon and colon carcinoma. Exp Mol Pathol 62: 118-122.
20. Nelson RL. (2001). Iron and colorectal cancer risk: human studies. Nutr Rev 59: 140-148.
21. Nelson WJ, Nusse R. (2004). Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487.
22. Norat T, Bingham S, Ferrari P et al. (2005). Meat, fish, and colorectal cancer risk. J Natl Cancer Inst 97: 906-916.
23. Oates PS, West AR. (2006). Heme in intestinal epithelial cell turnover, differentiation, detoxification, inflammation, carcinogenesis, absorption and motility. World J Gastroenterol 12: 4281-4295.
24. O'Donnell KA, Yu D, Zeller KI, Kim JW, Racke F, Thomas-Tikhonenko A et al. (2006). Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol Cell Biol 26: 2373-2386.
25. Orsulic S, Huber O, Aberle H, Arnold S, Kemler R. (1999). E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1- mediated transactivation. J Cell Sci 112: 1237-1245.
26. Palmer HG, Larriba MJ, Garcia JM, Ordonez-Moran P, Pena C, Peiro S et al. (2004). The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med 10: 917-919.
27. Penman GA, Leung L, Nathke IS. (2005). The adenomatous polyposis coli protein (APC) exists in two distinct soluble complexes with different functions. J Cell Sci 118: 4741-4750.
28. Pierre F, Tache S, Petit CR, Van der Meer R, Corpet DE. (2003). Meat and cancer: haemoglobin and haemin in a low-calcium diet promote colorectal carcinogenesis at the aberrant crypt stage in rats. Carcinogenesis 24: 1683-1690.
29. Rao AS, Kremenevskaja N, Resch J, Brabant G. (2005). Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. Eur J Endocrinol 153: 929-938.
30. Rouault TA. (2006). The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2: 406-414.
31. Segditsas S, Tomlinson I. (2006). Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25: 7531-7537.
32. Seril DN, Liao J, Ho KL, Warsi A, Yang CS, Yang GY. (2002). Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 47: 1266-1278.
33. Shaheen NJ, Silverman LM, Keku T, Lawrence LB, Rohlfs EM, Martin CF et al. (2003). Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Ins 95: 154-159.
34. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R et al. (1999). The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci 96: 5522-5527.
35. Toyokuni S. (1996). Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 20: 553-566.
36. Uzel C, Conrad ME. (1998). Absorption of heme iron. Semin Hematol 35: 27-34.
37. Wu KJ, Polack A, Dalla-Favera R. (1999). Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 283: 676-679.
38. Young GP, St John DJ, Rose IS, Blake D. (1990). Haem in the gut. J Gastroenterol Hepatol 5: 194-203.